China’s biopharma innovation is now approaching a critical inflection point, one that will determine whether it can move from efficiency advantage to value leadership over the next decade.
Our Latest Insights
报告
April 17, 2026
报告
March 26, 2026
面向未来十年,中国医药创新正处于从效率高地迈向价值高峰的关键拐点。
白皮书
February 5, 2026
Hong Kong has a clear pathway to potentially double the size of its fund industry by transitioning from legacy infrastructure to token-based finance.
报告
January 23, 2026
中信銀行與BCG再發臺灣超高資產洞察報告,透過多維度分析家族跨境配置與治理,並深化家族辦公室實務探討。
About BCG
As a top consulting firm, BCG helps clients with total transformation—driving complex change, enabling organizations to grow, and driving bottom-line impact.